Keenan LLC’s AstraZeneca AZN Stock Holding History

Keenan LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Sell	2,163 -103	-5%	-$19.4K	0.29%	29
2026 Q1	$447K	Hold	2,266	–	–	0.38%	28
2025 Q4	$417K	Buy	+2,266	New	+$397K	0.37%	29

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Keenan LLC's AZN Position: Q2 2026 in Review

Keenan LLC reduced its AstraZeneca (AZN) stake by 4.5% in Q2 2026, selling an estimated $19.4K and leaving 2,163 shares worth $410K. The position accounts for 0.29% of the portfolio, ranked #29.

Keenan LLC first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $447K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Keenan LLC held 2,163 shares of AstraZeneca worth $410K as of Q2 2026.
Keenan LLC sold 103 AstraZeneca shares in Q2 2026, an estimated $19.4K.
AstraZeneca made up 0.29% of Keenan LLC's portfolio in Q2 2026, its #29 holding.
Keenan LLC first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
Keenan LLC's AstraZeneca position peaked at $447K in Q1 2026.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Keenan LLC's 13F filing for Q2 2026, filed 7 Aug 2026.